MICROSOFT CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that MICROSOFT CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2010 | Jun 30, 2010 | $16.04B | Jul 30, 2010 |
| FY2010 | Mar 31, 2010 | $14.50B | Jul 30, 2010 |
| FY2010 | Dec 31, 2009 | $19.02B | Jul 30, 2010 |
| FY2010 | Sep 30, 2009 | $12.92B | Jul 30, 2010 |
| FY2010 | Jun 30, 2009 | $13.10B | Jul 30, 2010 |
| FY2010 | Mar 31, 2009 | $13.65B | Jul 30, 2010 |
| FY2010 | Dec 31, 2008 | $16.63B | Jul 30, 2010 |
| FY2010 | Sep 30, 2008 | $15.06B | Jul 30, 2010 |
| FY2010 | Jun 30, 2008 | $15.84B | Jul 30, 2010 |
| FY2010 | Mar 31, 2008 | $14.45B | Jul 30, 2010 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $281.72B | Jul 30, 2025 |
| FY2025 | Jun 30, 2024 | $245.12B | Jul 30, 2025 |
| FY2025 | Jun 30, 2023 | $211.92B | Jul 30, 2025 |
| FY2024 | Jun 30, 2022 | $198.27B | Jul 30, 2024 |
| FY2023 | Jun 30, 2021 | $168.09B | Jul 27, 2023 |
| FY2020 | Jun 30, 2020 | $38.03B | Jul 30, 2020 |
| FY2020 | Mar 31, 2020 | $35.02B | Jul 30, 2020 |
| FY2020 | Dec 31, 2019 | $36.91B | Jul 30, 2020 |
| FY2020 | Sep 30, 2019 | $33.06B | Jul 30, 2020 |
| FY2020 | Jun 30, 2019 | $33.72B | Jul 30, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jun 30, 2017 | $23.32B | Aug 2, 2017 |
| FY2017 | Mar 31, 2017 | $22.09B | Aug 2, 2017 |
| FY2017 | Dec 31, 2016 | $24.09B | Aug 2, 2017 |
| FY2017 | Sep 30, 2016 | $20.45B | Aug 2, 2017 |
| FY2017 | Jun 30, 2016 | $20.61B | Aug 2, 2017 |
| FY2017 | Mar 31, 2016 | $20.53B | Aug 2, 2017 |
| FY2017 | Dec 31, 2015 | $23.80B | Aug 2, 2017 |
| FY2017 | Sep 30, 2015 | $20.38B | Aug 2, 2017 |
| FY2016 | Jun 30, 2015 | $22.18B | Jul 28, 2016 |
| FY2016 | Mar 31, 2015 | $21.73B | Jul 28, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $193.89B | Jul 30, 2025 |
| FY2025 | Jun 30, 2024 | $171.01B | Jul 30, 2025 |
| FY2025 | Jun 30, 2023 | $146.05B | Jul 30, 2025 |
| FY2024 | Jun 30, 2022 | $135.62B | Jul 30, 2024 |
| FY2023 | Jun 30, 2021 | $115.86B | Jul 27, 2023 |
| FY2020 | Jun 30, 2020 | $25.69B | Jul 30, 2020 |
| FY2020 | Mar 31, 2020 | $24.05B | Jul 30, 2020 |
| FY2020 | Dec 31, 2019 | $24.55B | Jul 30, 2020 |
| FY2020 | Sep 30, 2019 | $22.65B | Jul 30, 2020 |
| FY2020 | Jun 30, 2019 | $23.31B | Jul 30, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $101.83B | Jul 30, 2025 |
| FY2025 | Jun 30, 2024 | $88.14B | Jul 30, 2025 |
| FY2025 | Jun 30, 2023 | $72.36B | Jul 30, 2025 |
| FY2024 | Jun 30, 2022 | $72.74B | Jul 30, 2024 |
| FY2023 | Jun 30, 2021 | $61.27B | Jul 27, 2023 |
| FY2020 | Jun 30, 2020 | $11.20B | Jul 30, 2020 |
| FY2020 | Mar 31, 2020 | $10.75B | Jul 30, 2020 |
| FY2020 | Dec 31, 2019 | $11.65B | Jul 30, 2020 |
| FY2020 | Sep 30, 2019 | $10.68B | Jul 30, 2020 |
| FY2020 | Jun 30, 2019 | $13.19B | Jul 30, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $128.53B | Jul 30, 2025 |
| FY2025 | Jun 30, 2024 | $109.43B | Jul 30, 2025 |
| FY2025 | Jun 30, 2023 | $88.52B | Jul 30, 2025 |
| FY2024 | Jun 30, 2022 | $83.38B | Jul 30, 2024 |
| FY2023 | Jun 30, 2021 | $69.92B | Jul 27, 2023 |
| FY2020 | Jun 30, 2020 | $13.41B | Jul 30, 2020 |
| FY2020 | Mar 31, 2020 | $12.98B | Jul 30, 2020 |
| FY2020 | Dec 31, 2019 | $13.89B | Jul 30, 2020 |
| FY2020 | Sep 30, 2019 | $12.69B | Jul 30, 2020 |
| FY2020 | Jun 30, 2019 | $12.41B | Jul 30, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $32.49B | Jul 30, 2025 |
| FY2025 | Jun 30, 2024 | $29.51B | Jul 30, 2025 |
| FY2025 | Jun 30, 2023 | $27.20B | Jul 30, 2025 |
| FY2024 | Jun 30, 2022 | $24.51B | Jul 30, 2024 |
| FY2023 | Jun 30, 2021 | $20.72B | Jul 27, 2023 |
| FY2022 | Jun 30, 2020 | $19.27B | Jul 28, 2022 |
| FY2021 | Jun 30, 2019 | $16.88B | Jul 29, 2021 |
| FY2020 | Jun 30, 2018 | $14.73B | Jul 30, 2020 |
| FY2019 | Jun 30, 2017 | $13.04B | Aug 1, 2019 |
| FY2018 | Jun 30, 2016 | $11.99B | Aug 3, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $136.16B | Jul 30, 2025 |
| FY2025 | Jun 30, 2024 | $118.55B | Jul 30, 2025 |
| FY2025 | Jun 30, 2023 | $87.58B | Jul 30, 2025 |
| FY2024 | Jun 30, 2022 | $89.04B | Jul 30, 2024 |
| FY2023 | Jun 30, 2021 | $76.74B | Jul 27, 2023 |
| FY2022 | Jun 30, 2020 | $60.68B | Jul 28, 2022 |
| FY2021 | Jun 30, 2019 | $52.19B | Jul 29, 2021 |
| FY2020 | Jun 30, 2018 | $43.88B | Jul 30, 2020 |
| FY2019 | Jun 30, 2017 | $39.51B | Aug 1, 2019 |
| FY2018 | Jun 30, 2016 | $33.33B | Aug 3, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $64.55B | Jul 30, 2025 |
| FY2025 | Jun 30, 2024 | $44.48B | Jul 30, 2025 |
| FY2025 | Jun 30, 2023 | $28.11B | Jul 30, 2025 |
| FY2024 | Jun 30, 2022 | $23.89B | Jul 30, 2024 |
| FY2023 | Jun 30, 2021 | $20.62B | Jul 27, 2023 |
| FY2022 | Jun 30, 2020 | $15.44B | Jul 28, 2022 |
| FY2021 | Jun 30, 2019 | $13.93B | Jul 29, 2021 |
| FY2020 | Jun 30, 2018 | $11.63B | Jul 30, 2020 |
| FY2019 | Jun 30, 2017 | $8.13B | Aug 1, 2019 |
| FY2018 | Jun 30, 2016 | $8.34B | Aug 3, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $619.00B | Jul 30, 2025 |
| FY2025 | Jun 30, 2024 | $512.16B | Jul 30, 2025 |
| FY2024 | Jun 30, 2023 | $411.98B | Jul 30, 2024 |
| FY2023 | Jun 30, 2022 | $364.84B | Jul 27, 2023 |
| FY2022 | Jun 30, 2021 | $333.78B | Jul 28, 2022 |
| FY2021 | Jun 30, 2020 | $301.31B | Jul 29, 2021 |
| FY2020 | Jun 30, 2019 | $286.56B | Jul 30, 2020 |
| FY2019 | Jun 30, 2018 | $258.85B | Aug 1, 2019 |
| FY2018 | Jun 30, 2017 | $250.31B | Aug 3, 2018 |
| FY2017 | Jun 30, 2016 | $193.47B | Aug 2, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $275.52B | Jul 30, 2025 |
| FY2025 | Jun 30, 2024 | $243.69B | Jul 30, 2025 |
| FY2024 | Jun 30, 2023 | $205.75B | Jul 30, 2024 |
| FY2023 | Jun 30, 2022 | $198.30B | Jul 27, 2023 |
| FY2022 | Jun 30, 2021 | $191.79B | Jul 28, 2022 |
| FY2021 | Jun 30, 2020 | $183.01B | Jul 29, 2021 |
| FY2020 | Jun 30, 2019 | $184.23B | Jul 30, 2020 |
| FY2019 | Jun 30, 2018 | $176.13B | Aug 1, 2019 |
| FY2018 | Jun 30, 2017 | $162.60B | Aug 3, 2018 |
| FY2017 | Jun 30, 2016 | $121.47B | Aug 2, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $343.48B | Jul 30, 2025 |
| FY2025 | Jun 30, 2024 | $268.48B | Jul 30, 2025 |
| FY2025 | Jun 30, 2023 | $206.22B | Jul 30, 2025 |
| FY2024 | Jun 30, 2022 | $166.54B | Jul 30, 2024 |
| FY2023 | Jun 30, 2021 | $141.99B | Jul 27, 2023 |
| FY2022 | Jun 30, 2020 | $118.30B | Jul 28, 2022 |
| FY2021 | Jun 30, 2019 | $102.33B | Jul 29, 2021 |
| FY2020 | Jun 30, 2018 | $82.72B | Jul 30, 2020 |
| FY2019 | Jun 30, 2017 | $87.71B | Aug 1, 2019 |
| FY2018 | Jun 30, 2016 | $83.09B | Aug 3, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $119.51B | Jul 30, 2025 |
| FY2025 | Jun 30, 2024 | $119.22B | Jul 30, 2025 |
| FY2025 | Jun 30, 2023 | $67.89B | Jul 30, 2025 |
| FY2024 | Jun 30, 2022 | $67.52B | Jul 30, 2024 |
| FY2023 | Jun 30, 2021 | $49.71B | Jul 27, 2023 |
| FY2022 | Jun 30, 2020 | $43.35B | Jul 28, 2022 |
| FY2021 | Jun 30, 2019 | $42.03B | Jul 29, 2021 |
| FY2020 | Jun 30, 2018 | $35.68B | Jul 30, 2020 |
| FY2019 | Jun 30, 2017 | $35.12B | Aug 1, 2019 |
| FY2018 | Jun 30, 2016 | $17.87B | Aug 3, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $237.73B | Jul 30, 2025 |
| FY2025 | Jun 30, 2024 | $173.14B | Jul 30, 2025 |
| FY2024 | Jun 30, 2023 | $118.85B | Jul 30, 2024 |
| FY2023 | Jun 30, 2022 | $84.28B | Jul 27, 2023 |
| FY2022 | Jun 30, 2021 | $57.06B | Jul 28, 2022 |
| FY2021 | Jun 30, 2020 | $34.57B | Jul 29, 2021 |
| FY2020 | Jun 30, 2019 | $24.15B | Jul 30, 2020 |
| FY2019 | Jun 30, 2018 | $13.68B | Aug 1, 2019 |
| FY2018 | Jun 30, 2017 | $17.77B | Aug 3, 2018 |
| FY2017 | Jun 30, 2016 | $2.28B | Aug 2, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $30.24B | Jul 30, 2025 |
| FY2025 | Jun 30, 2024 | $18.32B | Jul 30, 2025 |
| FY2024 | Jun 30, 2023 | $34.70B | Jul 30, 2024 |
| FY2023 | Jun 30, 2022 | $13.93B | Jul 27, 2023 |
| FY2022 | Jun 30, 2021 | $14.22B | Jul 28, 2022 |
| FY2021 | Jun 30, 2020 | $13.58B | Jul 29, 2021 |
| FY2020 | Jun 30, 2019 | $11.36B | Jul 30, 2020 |
| FY2019 | Jun 30, 2018 | $11.95B | Aug 1, 2019 |
| FY2019 | Jun 30, 2017 | $7.66B | Aug 1, 2019 |
| FY2019 | Jun 30, 2016 | $6.51B | Aug 1, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $43.15B | Jul 30, 2025 |
| FY2025 | Jun 30, 2024 | $44.94B | Jul 30, 2025 |
| FY2024 | Jun 30, 2023 | $47.24B | Jul 30, 2024 |
| FY2023 | Jun 30, 2022 | $49.78B | Jul 27, 2023 |
| FY2022 | Jun 30, 2021 | $58.15B | Jul 28, 2022 |
| FY2021 | Jun 30, 2020 | $63.33B | Jul 29, 2021 |
| FY2020 | Jun 30, 2019 | $72.18B | Jul 30, 2020 |
| FY2019 | Jun 30, 2018 | $76.20B | Aug 1, 2019 |
| FY2018 | Jun 30, 2017 | $77.10B | Aug 3, 2018 |
| FY2017 | Jun 30, 2016 | $40.60B | Aug 2, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 13 | Jul 30, 2025 |
| FY2025 | Jun 30, 2024 | 11 | Jul 30, 2025 |
| FY2025 | Jun 30, 2023 | 9 | Jul 30, 2025 |
| FY2024 | Jun 30, 2022 | 9 | Jul 30, 2024 |
| FY2023 | Jun 30, 2021 | 8 | Jul 27, 2023 |
| FY2020 | Jun 30, 2020 | 1 | Jul 30, 2020 |
| FY2020 | Mar 31, 2020 | 1 | Jul 30, 2020 |
| FY2020 | Dec 31, 2019 | 1 | Jul 30, 2020 |
| FY2020 | Sep 30, 2019 | 1 | Jul 30, 2020 |
| FY2020 | Jun 30, 2019 | 1 | Jul 30, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 13 | Jul 30, 2025 |
| FY2025 | Jun 30, 2024 | 11 | Jul 30, 2025 |
| FY2025 | Jun 30, 2023 | 9 | Jul 30, 2025 |
| FY2024 | Jun 30, 2022 | 9 | Jul 30, 2024 |
| FY2023 | Jun 30, 2021 | 8 | Jul 27, 2023 |
| FY2020 | Jun 30, 2020 | 1 | Jul 30, 2020 |
| FY2020 | Mar 31, 2020 | 1 | Jul 30, 2020 |
| FY2020 | Dec 31, 2019 | 1 | Jul 30, 2020 |
| FY2020 | Sep 30, 2019 | 1 | Jul 30, 2020 |
| FY2020 | Jun 30, 2019 | 1 | Jul 30, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 7.43B | Jul 30, 2025 |
| FY2025 | Jun 30, 2024 | 7.43B | Jul 30, 2025 |
| FY2025 | Jun 30, 2023 | 7.43B | Jul 30, 2025 |
| FY2025 | Jun 30, 2022 | 7.46B | Jul 30, 2025 |
| FY2024 | Jun 30, 2021 | 7.52B | Jul 30, 2024 |
| FY2023 | Jun 30, 2020 | 7.57B | Jul 27, 2023 |
| FY2022 | Jun 30, 2019 | 7.64B | Jul 28, 2022 |
| FY2021 | Jun 30, 2018 | 7.68B | Jul 29, 2021 |
| FY2020 | Jun 30, 2017 | 7.71B | Jul 30, 2020 |
| FY2019 | Jun 30, 2016 | 7.81B | Aug 1, 2019 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $24.08B | Jul 30, 2025 |
| FY2025 | Jun 30, 2024 | $21.77B | Jul 30, 2025 |
| FY2025 | Jun 30, 2023 | $19.80B | Jul 30, 2025 |
| FY2024 | Jun 30, 2022 | $18.14B | Jul 30, 2024 |
| FY2023 | Jun 30, 2021 | $16.52B | Jul 27, 2023 |
| FY2022 | Jun 30, 2020 | $15.14B | Jul 28, 2022 |
| FY2021 | Jun 30, 2019 | $13.81B | Jul 29, 2021 |
| FY2020 | Jun 30, 2018 | $12.70B | Jul 30, 2020 |
| FY2019 | Jun 30, 2017 | $11.85B | Aug 1, 2019 |
| FY2018 | Jun 30, 2016 | $11.01B | Aug 3, 2018 |